| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9326305 | Gynecologic Oncology | 2005 | 9 Pages |
Abstract
For the agents studied, acquired resistance was not a function of disease site. In vitro drug resistance observed at recurrence was not influenced significantly by intervening therapy. It is possible that assay results at diagnosis could be used to guide subsequent therapy at relapse, especially when recurrent tissue is not available for analysis.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Krishnansu S. Tewari, Rita S. Mehta, Robert A. Burger, Ing-Ru Yu, Ainura S. Kyshtoobayeva, Bradley J. Monk, Alberto Manetta, Michael L. Berman, Philip J. Disaia, John P. Fruehauf,